DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

Information source: St. Petersburg State Pavlov Medical University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Topiramate; Lamotrigine; Memnatine; Diazepam; Placebo

Intervention: Anticonvulsants (Drug)

Phase: N/A

Status: Completed

Sponsored by: St. Petersburg State Pavlov Medical University

Official(s) and/or principal investigator(s):
Evgeny M Krupitsky, MD, PhD, Principal Investigator, Affiliation: St. Petersburg State Pavlov Medical University

Summary

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Eligibility

Minimum age: 20 Years. Maximum age: 60 Years. Gender(s): Both.

Criteria:

Inclusion Criteria: Alcohol dependence Alcohol withdrawal syndrome Exclusion Criteria: Drug dependence Major psychiatric diagnoses Severe somatic illness

Locations and Contacts

Additional Information


Last updated: October 17, 2006

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017